Literature DB >> 10899377

Heroin-induced suppression of saccharin intake in water-deprived and water-replete rats.

P S Grigson1, R C Twining, R M Carelli.   

Abstract

Rats suppress intake of a saccharin conditioned stimulus (CS) when paired with an aversive unconditioned stimulus such as lithium chloride. This phenomenon is referred to as a conditioned taste aversion (CTA). Rats also suppress intake of a saccharin CS when paired with a rewarding sucrose solution and when paired with a drug of abuse. Although the suppressive effects of drugs of abuse have long been interpreted as CTAs, evidence suggests that rats may suppress intake of the saccharin CS following taste-drug pairings because they are anticipating the rewarding rather than the aversive properties of the drug. Oddly, however, while all other drugs of abuse tested suppress intake of a gustatory CS, the highly reinforcing drug, heroin, is reportedly ineffective. The present study reexamined this issue in both water-deprived and water-replete rats using procedures that sustain both morphine- and cocaine-induced suppression of CS intake. The results showed that heroin greatly reduced CS intake following saccharin-heroin pairings and that this effect was less variable when assessed in water-replete subjects. When taken with other reports, these data suggest that rats suppress intake of a saccharin CS in anticipation of the availability of all drugs of abuse tested.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10899377     DOI: 10.1016/s0091-3057(00)00253-7

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  15 in total

1.  The ontogeny of ethanol aversion.

Authors:  Jessica Saalfield; Linda Spear
Journal:  Physiol Behav       Date:  2016-01-13

2.  Appetitive sensitization by amphetamine does not reduce its ability to produce conditioned taste aversion to saccharin.

Authors:  John Scott-Railton; Gretchen Arnold; Paul Vezina
Journal:  Behav Brain Res       Date:  2006-10-04       Impact factor: 3.332

3.  Differential involvement of the norepinephrine, serotonin and dopamine reuptake transporter proteins in cocaine-induced taste aversion.

Authors:  Jermaine D Jones; F Scott Hall; George R Uhl; Kenner Rice; Anthony L Riley
Journal:  Pharmacol Biochem Behav       Date:  2009-04-17       Impact factor: 3.533

4.  Drug-motivated behavior in rats with lesions of the thalamic orosensory area.

Authors:  Jennifer E Nyland; Danielle N Alexander; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2015-12-14       Impact factor: 1.912

5.  Reward Comparison: The Achilles' heel and hope for addiction.

Authors:  Patricia Sue Grigson
Journal:  Drug Discov Today Dis Models       Date:  2008

6.  The role of dose and restriction state on morphine-, cocaine-, and LiCl-induced suppression of saccharin intake: A comprehensive analysis.

Authors:  Robert C Twining; Christopher S Freet; Robert A Wheeler; Christian G Reich; Dennie A Tompers; Sarah E Wolpert; Patricia S Grigson
Journal:  Physiol Behav       Date:  2016-04-13

7.  Gustatory insular cortex lesions disrupt drug-induced, but not lithium chloride-induced, suppression of conditioned stimulus intake.

Authors:  Rastafa I Geddes; Li Han; Anne E Baldwin; Ralph Norgren; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

Review 8.  The state of the reward comparison hypothesis: theoretical comment on Huang and Hsiao (2008).

Authors:  Patricia Sue Grigson
Journal:  Behav Neurosci       Date:  2008-12       Impact factor: 1.912

9.  Prior access to a sweet is more protective against cocaine self-administration in female rats than in male rats.

Authors:  Angie M Cason; Patricia S Grigson
Journal:  Physiol Behav       Date:  2013-03-06

10.  Greater avoidance of a heroin-paired taste cue is associated with greater escalation of heroin self-administration in rats.

Authors:  Caesar G Imperio; Patricia S Grigson
Journal:  Behav Neurosci       Date:  2015-08       Impact factor: 1.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.